Komori
General Meetings of Shareholders4888STELLA PHARMA CORPORATIONPharmaceuticals

Notice of Convocation of the 19th Annual General Meeting of Shareholders

At the 19th Annual General Meeting of Shareholders, the company is seeking the election of 4 Directors, 3 Directors who are Audit and Supervisory Committee Members, and 1 substitute Director who is an Audit and Supervisory Committee Member. Of the candidates for Directors who are Audit and Supervisory Committee Members, 1 is a new candidate, and the proposed lineup includes outside candidates.

Worth reading
53Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Resolutions for the General Meeting of Shareholders

Annual General Meeting, 19th fiscal term
2026
Jun 24
Date and time23 days from this disclosure to the meeting
Matters for resolution3 items
  1. Election of 4 directors, excluding directors who are Audit & Supervisory Committee members

  2. Election of 3 directors who are Audit and Supervisory Committee members

  3. Election of 1 alternate director who is an Audit and Supervisory Committee Member

Shareholder Proposal

No

A shareholder proposal is a resolution submitted by a shareholder, rather than by the company.
Director nominee
8Nominees
1New
4Outside
Resolutions for the General Meeting of Shareholders
ItemDetails
Type of shareholders' meetingAnnual General Meeting, 19th fiscal term
Date and time10:00 a.m. on Wednesday, 24 June 2026
Matters for resolutionProposal No. 1: Election of 4 directors, excluding directors who are Audit & Supervisory Committee members, Proposal No. 2: Election of 3 directors who are Audit and Supervisory Committee members, Proposal No. 3: Election of 1 alternate director who is an Audit and Supervisory Committee Member
Shareholder ProposalNo
Director nominee8 candidates (including 1 new candidate and 4 outside candidates)
Items this document does not state (1)
Percentage voting in favor

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To elect Directors and Directors who are Audit and Supervisory Committee Members whose terms of office are expiring, and to elect a substitute candidate in preparation for any shortfall in the number of Audit and Supervisory Committee Members. The company explains that each candidate is expected to contribute to management and the auditing and supervisory functions by drawing on their specialized knowledge and experience.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice of Convocation of the 19th Annual General Meeting of Shareholders | STELLA PHARMA CORPORATION (4888) timely disclosure | Komori